DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



ASTERIX: Low Dose ASA and Nexium

Information source: AstraZeneca
Information obtained from ClinicalTrials.gov on December 31, 2007
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Gastroesophageal Reflux

Intervention: Esomeprazole (Drug)

Phase: Phase 3

Status: Completed

Sponsored by: AstraZeneca

Official(s) and/or principal investigator(s):
AstraZeneca Nexium Medical Science Director, MD, Study Director, Affiliation: AstraZeneca
Neville Yeomans, MD, Principal Investigator, Affiliation: Perth Medical School

Summary

The purpose of the study is to evaluate the effect of esomeprazole 20 mg od versus placebo for the prevention of gastric and/or duodenal ulcers in patients taking low-dose ASA.

Clinical Details

Official title: A Randomized Double-Blind Placebo-Controlled Study to Assess the Prevention of Low-Dose Acetylsalicylic Acid (ASA) Associated Gastroduodenal Lesions and Upper Gastrointestinal Symptoms in Patients Taking Esomeprazole 20 Mg Once Daily for 26 Weeks.

Study design: Prevention, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Efficacy Study

Primary outcome: The primary variable is presence of gastric and/or duodenal ulcers at endoscopy over a 26-week period in patients taking low-dose ASA.

Secondary outcome: LA classification for the oesophagus at endoscopy. Upper GI symptoms assessed by the investigator at each study visit.

Eligibility

Minimum age: 60 Years. Maximum age: N/A. Gender(s): Both.

Criteria:

Inclusion Criteria: A clinical diagnosis of a condition (cardiovascular and/or cerebrovascular protection or other reasons) that requires daily intake of low-dose ASA, 75-325 mg, and is expected to continue for the duration of the study (daily is defined as at least 5 days per week). Age >= 60 years. No gastric and/or duodenal ulcer at the baseline endoscopy. H. pylori negative by serology test at screening. Exclusion Criteria: Upper GI symptoms Erosive oesophagitis Malignancy

Locations and Contacts

Research Site, Burgas, Bulgaria

Research Site, Pleven, Bulgaria

Research Site, Russe, Bulgaria

Research Site, Sofia, Bulgaria

Research Site, Varna, Bulgaria

Research Site, Quebec, Canada

Research Site, Hamburg, Germany

Research Site, Herne, Germany

Research Site, Köln, Germany

Research Site, Künzing, Germany

Research Site, Lienen, Germany

Research Site, Lüdenscheid, Germany

Research Site, Ludwigshafen, Germany

Research Site, MÜNSTER, Germany

Research Site, Oelde, Germany

Research Site, Paderborn, Germany

Research Site, Potsdam, Germany

Research Site, Ribnitz-Damgarten, Germany

Research Site, Rostock, Germany

Research Site, Siegen, Germany

Research Site, Wangen, Germany

Research Site, Wiesbaden, Germany

Research Site, Wolfenbüttel, Germany

Research Site, Wolmirstedt, Germany

Research Site, Zeven, Germany

Research Site, Athens, Greece

Research Site, Ioannina, Greece

Research Site, Piraeus, Greece

Research Site, Thessaloniki, Greece

Research Site, Hong Kong, Hong Kong

Research Site, Budapest, Hungary

Research Site, Debrecen, Hungary

Research Site, Eger, Hungary

Research Site, Gy¿r, Hungary

Research Site, Gyula, Hungary

Research Site, Kecskemét, Hungary

Research Site, Miskolc, Hungary

Research Site, Vác, Hungary

Research Site, Napoli, Italy

Research Site, Roma, Italy

Research Site, Cape Town, South Africa

Research Site, Johannesurg, South Africa

Research Site, Lyttelton Manor, South Africa

Research Site, Parktown, South Africa

Research Site, Tygerberg, South Africa

Research Site, Granada, Spain

Research Site, Madrid, Spain

Research Site, Murcia, Spain

Research Site, Sevilla, Spain

Research Site, Edinburgh, United Kingdom

Research Site, Santiago, A Coruña, Spain

Research Site, Santiago de Compostela, A Coruña, Spain

Research Site, Edmonton, Alberta, Canada

Research Site, Irvine, Ayrshire, United Kingdom

Research Site, Bologna, BO, Italy

Research Site, Stuttgart, Baden-Württemberg, Germany

Research Site, München, Bayern, Germany

Research Site, Cottbus, Brandenburg, Germany

Research Site, Genova, GE, Italy

Research Site, San Sebastián, Guipuzcoa, Spain

Research Site, Frankfurt, Hessen, Germany

Research Site, Winnipeg, Manitoba, Canada

Research Site, Rostock, Mecklenburg-Vorpommern, Germany

Research Site, Bondi Junction, New South Wales, Australia

Research Site, Bay Roberts, Newfoundland and Labrador, Canada

Research Site, Carbonear, Newfoundland and Labrador, Canada

Research Site, St. John's, Newfoundland and Labrador, Canada

Research Site, Hannover, Niedersachsen, Germany

Research Site, Düsseldorf, Nordrhein-Westfalen, Germany

Research Site, MÜNSTER, Nordrhein-Westfalen, Germany

Research Site, Halifax, Nova Scotia, Canada

Research Site, Hamilton, Ontario, Canada

Research Site, London, Ontario, Canada

Research Site, North York, Ontario, Canada

Research Site, Sudbury, Ontario, Canada

Research Site, Thornhill, Ontario, Canada

Research Site, Toronto, Ontario, Canada

Research Site, Oakville, Ontario, Canada

Research Site, Parma, PR, Italy

Research Site, Parkdale, Prince Edward Island, Canada

Research Site, Courcelette, Quebec, Canada

Research Site, Bracken Ridge, Queensland, Australia

Research Site, Carina Heights, Queensland, Australia

Research Site, Mainz, Rheinland-Pfalz, Germany

Research Site, Halle, Sachsen-Anhalt, Germany

Research Site, Glasgow, Scotland, United Kingdom

Research Site, Adelaide, South Australia, Australia

Research Site, Ashford, South Australia, Australia

Research Site, Wayville, South Australia, Australia

Research Site, Woodville, South Australia, Australia

Research Site, Cardiff, South Wales, United Kingdom

Research Site, Ballarat, Victoria, Australia

Research Site, Malvern, Victoria, Australia

Additional Information

Starting date: May 2004
Last updated: November 9, 2005

Page last updated: December 31, 2007

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009